03-16-2020, 04:46 AM
|
 |
Senior Member
|
|
Join Date: Mar 2017
Location: ABQ, New Mexico
Posts: 36,633
Thanks: 3,506
Thanked 136,542 Times in 22,784 Posts
|
|
Inovio Pharmaceuticals set to trial Covid-19 vaccine in April
Quote:
Inovio Pharmaceuticals has expedited its timeline for the development of a Covid-19 vaccine candidate, INO-4800, with human clinical trials scheduled for April.
The company already had a vaccine candidate in Phase II development for similar coronavirus that leads to the development of Middle East Respiratory Syndrome (MERS).
Inovio leveraged its DNA medicines platform to design INO-4800 within three hours of the publication of the novel coronavirus’ genetic sequence.
In January, the company started preclinical testing of the Covid-19 vaccine candidate and obtained funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to support preclinical and initial clinical development.
Preclinical testing is ongoing, while the company developed and finalised human clinical trial designs. Inovio has generated 3,000 INO-4800 doses for trials conducted in patients across the US, China and South Korea.
|
https://www.pharmaceutical-technolog...cine-timeline/
|